Targeting ROS-induced osteoblast senescence and RANKL production by Prussian blue nanozyme based gene editing platform to reverse osteoporosis

Ke Li, Sihan Hu, Jinhua Huang, Yu Shi, Wenzheng Lin, Xiangyu Liu, Wenwen Mao, Chunbiao Wu, Chun Pan, Zhuobin Xu, Huihui Wang, Lizeng Gao, Hao Chen